NCT06251596

Brief Summary

This study aims to evaluate endometrial thickness on the day of the frozen embryo transfer, compared to endometrial thickness on the last day of assessment of the endometrium before exposure to progesterone in respect to the protocols used for endometrial preparation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
247

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2023

Enrollment Period

2.9 years

First QC Date

February 1, 2024

Last Update Submit

February 1, 2024

Conditions

IVF

Outcome Measures

Primary Outcomes (1)

  • Endometrial compaction in each group.

    Endometrial compaction in each group.

    5 years

Secondary Outcomes (1)

  • Implantation and pregnancy rates in each group

    5 years

Study Arms (2)

Patients with ovulatory cycles

Patients with ovulatory cycles

Patients with artificial cycles

Patients with artificial cycles

Eligibility Criteria

Age20 Years - 44 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales only
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

250 IVF patients undergoing the return of frozen embryos

You may not qualify if:

  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, Heifa Region, 38810101, Israel

Location

Study Officials

  • Einat Shalom Paz, PROF

    Israel Hillel Yaffe medical center

    PRINCIPAL INVESTIGATOR

  • Anna Turetzky Oved, Nurse

    Israel Hillel Yaffe medical center

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2024

First Posted

February 9, 2024

Study Start

January 25, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

February 9, 2024

Record last verified: 2023-02

Locations

IL(1)